Skip to main navigation
LinkedIn Twitter
  • Investors
  • Careers
Outlook Therapeutics, Inc. Logo
  • About
    • Overview
    • Senior Leadership
    • Board of Directors
  • Pipeline
    • ONS-5010 / LYTENAVA™ OVERVIEW
    • ONS-5010 CLINICAL PROGRESS
    • UNMET PATIENT NEEDS
    • REPACKAGED IV BEVACIZUMAB
    • NEW OPHTHALMIC ANTI-VEGF
    • POTENTIAL FIRST-LINE THERAPY
  • News
  • Contact

SEC Filings

Home / Investors / SEC Filings / CT ORDER

SEC Filing Details

Document Details

Form
CT ORDER
Filing Date
May 16, 2016
Document Date
May 16, 2016
Form Description
CT ORDER
Filing Group
Other
Company
Outlook Therapeutics, Inc.
Issuer
OUTLOOK THERAPEUTICS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
  • Investor Overview
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Other Shareholder Information
  • Financial Information
    • SEC Filings
  • Analyst Coverage
  • News & Events
    • Press Releases
    • Events
    • In the News
    • Presentations
  • Corporate Governance
    • Governance Highlights
    • Board Diversity Disclosure
    • Senior Leadership
    • Board of Directors
    • Committee Composition
  • Information Request
  • Print Page Print Page
  • Email Page Email Page
  • RSS Feeds RSS Feeds
  • Email Alerts Email Alerts
  • Contact IR Contact IR
© 2023 Outlook Therapeutics, Inc.
Privacy Policy | Disclaimer